© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e Nr 09/2013
754
P R A C E O R Y G I N A L N E ginekologia
+MRIOSP4SP
Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia
Szacowane ryzyko raka sutka oraz wyniki badań skriningowych u przedmenopauzalnych kobiet z niecykliczną mastalgią
/HFK5RJXOVNL-DQ%LĔF]\N
“Medyk-Centrum” Private Medical Center, Gynecology and Breast Diseases Clinic, Czestochowa, Poland
Abstract
Objectives: Breast pain is a common but worrisome symptom, which can cause a significant psychological bur- den of cancer stress. It is not known whether breast cancer risk estimation models can be used as an adjunct to the clinical and radiological assessment in counseling women with mastalgia. The aim of our study was to compare the estimated breast cancer risk and screening outcomes between patients with mastalgia and women requesting prophylactic examinations.
Material and methods: 112 premenopausal women with non-cyclic breast pain and 182 control women who presented for prophylactic examination were screened with mammography and ultrasound. Breast cancer risk esti- mated with the Gail and Tyrer-Cuzick models along with screening outcomes were compared between the groups.
Results: Premenopausal patients with mastalgia had lower estimated breast cancer risk than controls. The dif- ference was observed with both the Gail and Tyrer-Cuzick models (Gail 5-year risk: 0.66 ± 0.4% vs. 0.77 ± 0.4%, p=0.0002; Tyrer-Cuzick 5-year risk: 0.85 ± 0.4% vs. 0.95 ± 0.3%, p=0.002; Gail lifetime risk: 8.98 ± 3.6% vs. 9.6 ± 3.9%, p=0.015; Tyrer-Cuzick lifetime risk: 8.3 ± 3.1 % vs. 8.9 ± 2.7 %, p=0.045). Radiological and clinical outcomes were comparable between the groups.
Conclusions: Breast pain was associated with lower estimated breast cancer risk but had no effect on screening outcomes in the study population.
Keywords: breast cancer / breast pain / risk assessment / statistical models /
Otrzymano: 05.11.2012
Zaakceptowano do druku: 10.06.2013 Adres do korespondencji:
Lech Rogulski
“Medyk-Centrum” Private Medical Center, Gynecology and Breast Diseases Clinic, Czestochowa, Poland, 42-200 Czestochowa, al. Wolności 34
tel. +48 34 654666; fax.: +48 34 3683430 e-mail: lech.rogulski@gmail.com
© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e
Nr 09/2013
755
P R A C E O R Y G I N A L N E ginekologia +MRIOSP4SP
Lech Rogulski, Jan Bińczyk. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.
Introduction
(SLGHPLRORJLFDO PRGHOV IRU EUHDVW FDQFHU ULVN HVWLPDWLRQ
DUHSURYHQDQGUHOLDEOHWRROVIRULGHQWL¿FDWLRQRIZRPHQZKRDUH
PRUHOLNHO\WRGHYHORSEUHDVWFDQFHUDQGPD\UHTXLUHDGGLWLRQDO
VFUHHQLQJPHDVXUHVRUSUHYHQWLYHLQWHUYHQWLRQV>@+RZHYHU
WKH\ KDYH QRW \HW EHHQ XVHG DV DQ DGMXQFW WR WKH FOLQLFDO DQG
UDGLRORJLFDO DVVHVVPHQW LQ FRXQVHOLQJ ZRPHQ ZLWK FRPPRQ
EUHDVWV\PSWRPVVXFKDVPDVWDOJLD
Objective
7KHDLPRIRXUVWXG\ZDVWRHVWDEOLVKZKHWKHUSUHPHQRSDXVDO
ZRPHQ ZLWK EUHDVW SDLQ KDYH GLIIHUHQW HVWLPDWHG EUHDVW FDQFHU
ULVNDQGVFUHHQLQJRXWFRPHVFRPSDUHGWRDV\PSWRPDWLFZRPHQ
UHTXHVWLQJSURSK\ODFWLFH[DPLQDWLRQ
Materials and methods
&URVVVHFWLRQDO VWXG\ SUHPHQRSDXVDO SDWLHQWV ZKR
SUHVHQWHG WR D EUHDVW GLVHDVHV FOLQLF ZLWK QRQF\FOLF PDVWDOJLD
EHWZHHQ 0D\ DQG 0D\ ZHUH DVVHVVHG FOLQLFDOO\
LQFOXGLQJ FOLQLFDO EUHDVW H[DPLQDWLRQ DQG VFUHHQHG ZLWK
PDPPRJUDSK\ DQG EUHDVW XOWUDVRXQG PDVWDOJLD JURXS
SUHPHQRSDXVDO ZRPHQ ZKR SUHVHQWHG LQ WKH VDPH SHULRG IRU
SURSK\ODFWLF H[DPLQDWLRQV XQGHUZHQW LGHQWLFDO SURFHGXUH DQG
ZHUHXVHGDVDFRQWUROJURXS
1RQF\FOLFPDVWDOJLDZDVGH¿QHGDVDORFDOL]HGXQLODWHUDO
RUELODWHUDOEUHDVWSDLQXQUHODWHGWRDPHQVWUXDOF\FOHRIPRUH
WKDQWKUHHPRQWKVLQGXUDWLRQ$GGLWLRQDOLQFOXVLRQFULWHULDZHUH
DJH EHWZHHQ \HDUV SUHPHQRSDXVDO VWDWXV ZLWK UXOHG RXW
SUHJQDQF\ 3DWLHQWV ZLWK SRVLWLYH SHUVRQDO KLVWRU\ IRU EUHDVW
FDQFHU RU FOLQLFDOO\ SDOSDEOH EUHDVW RU D[LOODU\ OHVLRQV ZHUH
H[FOXGHG IURP WKH VWXG\7KH VWXG\ ZDV DSSURYHG E\ WKH ORFDO
ELRHWKLFDOFRPPLWWHHDQGDOOZRPHQVLJQHGDQLQIRUPHGFRQVHQW
IRUPEHIRUHSDUWLFLSDWLQJ
,QGLYLGXDOEUHDVWFDQFHUULVNZDVFDOFXODWHGIURPWKHPRGL¿HG
*DLO DQG 7\UHU&X]LFN PRGHOV > @ 8OWUDVRXQG H[DPLQDWLRQV
ZHUH SHUIRUPHG XVLQJ $ORND 3UR6RXQG 66' HTXLSSHG
ZLWK 0+] OLQHDU SUREH E\ D J\QHFRORJLVW WUDLQHG LQ EUHDVW
VRQRJUDSK\0DPPRJUDSKLFH[DPLQDWLRQVZHUHSHUIRUPHGXVLQJ
6LHPHQV1RYDWLRQGLJLWDOPDPPRJUDSK\V\VWHPDQGDVVHVVHGE\
WZRLQGHSHQGHQWUDGLRORJLVWV)XUWKHUGLDJQRVWLFDQGWKHUDSHXWLF
VWHSVZHUHSURYLGHGDFFRUGLQJWRQDWLRQDORQFRORJLFDOJXLGHOLQHV
UHJDUGOHVVRIWKHHVWLPDWHGEUHDVWFDQFHUULVN
3HUVRQDO GHPRJUDSKLF DQG UHSURGXFWLYH GDWD HVWLPDWHG
EUHDVWFDQFHUULVNUDGLRORJLFDOVWXGLHVUHVXOWVDQGUHOHYDQWFOLQLFDO
RXWFRPHVZHUHFRPSDUHGEHWZHHQWKHJURXSV)LVKHUVH[DFWWHVW
DQG 0DQQ:KLWQH\V 8 WHVW ZHUH XVHG WR FRPSDUH FDWHJRULFDO
DQG FRQWLQXRXV YDULDEOHV UHVSHFWLYHO\ 3YDOXHV OHVV WKDQ
ZHUHFRQVLGHUHGVWDWLVWLFDOO\VLJQL¿FDQW0XOWLYDULDWHOLQHDUDQG
ORJLVWLF UHJUHVVLRQ ZDV XVHG WR DVFHUWDLQ WKDW HDFK YDULDEOH LV
LQGHSHQGHQWO\VLJQL¿FDQW'DWDZHUHDQDO\]HGZLWK67$7,67,&$
VRIWZDUH6WDWVRIW,QF Results
3DWLHQWV ZLWK PDVWDOJLD KDG ORZHU PHDQ HVWLPDWHG EUHDVW
FDQFHU ULVN WKDQ WKH SURSK\ODFWLF JURXS 7KH GLIIHUHQFH ZDV
REVHUYHGZLWKERWK*DLODQG7\UHU&X]LFNPRGHOV3DWLHQWVZLWK
PDVWDOJLDJDYH¿UVWOLYHELUWKVHDUOLHUDQGWKHWLPHVSDQEHWZHHQ
PHQDUFKHDQGWKH¿UVWOLYHELUWKZDVVLJQL¿FDQWO\VKRUWHULQWKDW
JURXS 7KHUH ZHUH QR VLJQL¿FDQW GLIIHUHQFHV LQ RWKHU SHUVRQDO
FKDUDFWHULVWLFVIUHTXHQF\RISRVLWLYHIDPLO\KLVWRU\UDGLRORJLFDO
DQG FOLQLFDO RXWFRPHV 6WXG\ UHVXOWV DUH VXPPDUL]HG LQ Table 1 8OWUDVRXQG H[DPLQDWLRQ GHWHFWHG RQH FDQFHU FDVH PLVVHG E\
PDPPRJUDSK\LQWKHSURSK\ODFWLFJURXS7KUHHRIWKHGHWHFWHG
EUHDVWFDQFHUVZHUHVWDJH,$DQGRQHZDVVWDJH,%
Discussion
%UHDVW SDLQ LV WKH PRVW FRPPRQ EUHDVW V\PSWRP ,WV
SDWKRSK\VLRORJ\LVDVVRFLDWHGSULPDULO\ZLWKHQGRFULQHGLVRUGHUV
EXWWKHGHWDLOVUHPDLQSRRUO\XQGHUVWRRG8SWRRIZRPHQ
H[SHULHQFHUHJXODUSUHPHQVWUXDOGLVFRPIRUWZKLOHDSSUR[LPDWHO\
Streszczenie
Cel pracy: Ból sutków jest częstym, lecz niepokojącym dla kobiety objawem, mogącym powodować lęk o jego potencjalnie nowotworowe przyczyny. Przy klinicznej i radiologicznej ocenie kobiet z mastalgią nie stosowano do tej pory analizy ryzyka raka sutka przy wykorzystaniu modeli statystycznych. Celem naszej pracy było porównanie szacowanego ryzyka raka sutka oraz wyników badań obrazowych pomiędzy pacjentkami z mastalgią a kobietami zgłaszającymi się w celu przeprowadzenia badań profilaktycznych sutków.
Materiał i metody: 112 przedmenopauzalnych pacjentek z niecyklicznym bólem sutków oraz 182 kobiety zgła- szające się do badania profilaktycznego poddano mammografii oraz ultrasonografii sutków. Porównano pomiędzy grupami ryzyko zachorowania na raka sutka oszacowane przy użyciu modelu Gail’a oraz Tyrer-Cuzick’a jak również wyniki badań skriningowych.
Wyniki: Przedmenopauzalne pacjentki z mastalgią miały niższe szacowane ryzyko zachorowania na raka sutka w porównaniu z grupą kontrolną. Różnice obserwowano zarówno dla modelu Gail’a jak i Tyrer-Cuzick’a (5-letnie ryzyko wg Gail’a 0.66 ± 0.4% vs. 0.77 ± 0.4%, p=0.0002; 5-letnie ryzyko wg Tyrer-Cuzick’a: 0.85 ± 0.4% vs. 0.95
± 0.3%, p=0.002; całkowite ryzyko wg Gail’a: 8.98 ± 3.6% vs. 9.6 ± 3.9%, p=0.015; całkowite ryzyko wg Tyrer-Cu- zick’a: 8.3 ± 3.1 % vs. 8.9 ± 2.7 %, p=0.045). Wyniki kliniczne i radiologiczne nie różniły się istotnie.
Wnioski: Ból sutków był związany z niższym szacowanym ryzykiem raka sutka, lecz nie miał wpływu na wyniki badań skriningowych w badanej populacji.
Słowa kluczowe: rak sutka / ból sutka / ocena ryzyka / modele statystyczne /
© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e Nr 09/2013
756
P R A C E O R Y G I N A L N E
ginekologia +MRIOSP4SP
Lech Rogulski, Jan Bińczyk. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.
RI ZRPHQ H[SHULHQFH PRGHUDWH WR VHYHUH EUHDVW SDLQ IRU
PRUHWKDQGD\VLQDPRQWK$ERXWKDOIRIWKHZRPHQZLWKVHYHUH
EUHDVWSDLQORRNIRUPHGLFDOKHOS>@6WXGLHVXVLQJ0F*LOOSDLQ
TXHVWLRQQDLUHKDYHVKRZQWKDWEUHDVWSDLQFDQEHDVLQWHQVHDVWKH
V\PSWRPVRIUKHXPDWRLGDUWKULWLVRUPHWDVWDWLFFDQFHU>@:RPHQ
RIWHQLQWHUSUHWEUHDVWSDLQDVDVLJQRIEUHDVWFDQFHU&ODVVLFDOO\
GHVFULEHGEUHDVWFDQFHUSDLQLVRQHVLGHGLQWHQVHDQGRIFRQVWDQW
LQWHQVLW\ ,Q WHUPV RI SUHVHQWDWLRQ LW FRUUHVSRQGV WR QRQF\FOLF
PDVWDOJLD >@$OWKRXJK REVHUYDWLRQDO DQG UHWURVSHFWLYH VWXGLHV
FRQGXFWHG LQ V DVVHVVHG WKDW WKH ULVN RI GHWHFWLQJ EUHDVW
FDQFHU LQ D SDWLHQWZLWK QRQF\FOLFPDVWDOJLDLV EHWZHHQ DQG
QHZHUVWXGLHV\LHOGHGFRQWUDGLFWRU\UHVXOWV>@'XMLPHW
DOKDYHHYHQVKRZQWKDWSDWLHQWVZLWKEUHDVWSDLQKDYHVOLJKWO\
ORZHUULVNRIGHWHFWLQJFDQFHURQVFUHHQLQJPDPPRJUDSK\WKDQ
DV\PSWRPDWLFZRPHQZKRSUHVHQWIRUSURSK\ODFWLFH[DPLQDWLRQV
YV>@
7KH UHVXOWV RI RXU VWXG\ LQGLFDWHG WKDW EUHDVW SDLQ ZDV
QRW DVVRFLDWHG ZLWK DQ LQFUHDVHG HVWLPDWHG EUHDVW FDQFHU ULVN
DVVHVVHGZLWKWKH*DLODQG7\UHU&X]LFNPRGHOVRUGLIIHUHQFHLQ
VFUHHQLQJRXWFRPHV7KHULVNHVWLPDWHVLQSDWLHQWVZLWKPDVWDOJLD
ZHUH DFWXDOO\ ORZHU WKDQ LQ ZRPHQ UHTXHVWLQJ SURSK\ODFWLF
H[DPLQDWLRQV 7KLV ZDV DWWULEXWDEOH WR D PRUH IDYRUDEOH
Table I. Study results.
Mastalgia Prophylactic P
N 112 182
$JH\HDUV NS
+HLJKWP NS
%0,NJP NS
$JHDWPHQDUFKH\HDUV NS
$JHDW¿UVWOLYHELUWK\HDUV #
1XOOLSDULW\ NS
7LPHEHWZHHQPHQDUFKHDQG¿UVWOLYHELUWK
\HDUV #
3UHYLRXVEUHDVWELRSVLHV NS
Positive family history for:
%UHDVWFDQFHUWRWDO NS
UHODWLYH NS
UHODWLYHV NS
2YDULDQFDQFHU NS
Estimated breast cancer risk:
*DLO\HDUULVN #
*DLOOLIHWLPHULVN #
7\UHU&X]LFN\HDUULVN #
7\UHU&X]LFNOLIHWLPHULVN #
Radiological and clinical outcomes:
0DPPRJUDSKLFDOO\GHQVHEUHDVWV$PHULFDQ
&ROOHJHRI5DGLRORJ\FODVVDQG NS
)LEURF\VWLFFKDQJHV NS
6KRUWWHUPIROORZXSQHHGHG NS
%LRSV\QHHGHG NS
,QYDVLYHFDQFHUGHWHFWHG NS
&RQWLQXRXVYDULDEOHVH[SUHVVHGDVPHDQVVWDQGDUGGHYLDWLRQSURSRUWLRQVH[SUHVVHGDVDEVROXWHYDOXHVDQG
SHUFHQWDJHV
#0DQQ:KLWQH\V8WHVW16QRWVLJQL¿FDQW
© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e
Nr 09/2013
757
P R A C E O R Y G I N A L N E ginekologia +MRIOSP4SP
Lech Rogulski, Jan Bińczyk. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.
UHSURGXFWLYHKLVWRU\7KHVWXG\ZDVWKH¿UVWWRDVVHVVEUHDVWFDQFHU
ULVNHVWLPDWLRQPRGHOVLQWKHSRSXODWLRQRIZRPHQZLWKEUHDVW
SDLQ,WVUHVXOWVKRZHYHULQGLUHFWO\VWDQGLQOLQHZLWKWKHFLWHG
PRUH UHFHQW VWXGLHV LQGLFDWLQJ WKDW PDVWDOJLD LV QRW DVVRFLDWHG
ZLWKHOHYDWHGEUHDVWFDQFHUULVN,WLVDOVRRQHRIWKH¿UVWVWXGLHV
FRYHULQJWKHDSSOLFDWLRQRIEUHDVWFDQFHUULVNHVWLPDWLRQPRGHOV
LQD3ROLVKSRSXODWLRQ>@
/LPLWDWLRQVDSSO\ZKHQLQWHUSUHWLQJWKHUHVXOWVRIRXUVWXG\,WV
FURVVVHFWLRQDOFKDUDFWHUGRHVQRWDOORZDQ\SUHPLVHRQDEVROXWH
EUHDVWFDQFHUULVNLQSDWLHQWVZLWKPDVWDOJLD,WVFRQFOXVLRQVUHO\
RQ WKH DVVXPSWLRQ WKDW EUHDVW SDLQ LV QRW DQ LQGHSHQGHQW ULVN
IDFWRUIRUEUHDVWFDQFHUDQGUHSUHVHQWVDFURVVSURGXFWRIYDULRXV
UHSURGXFWLYH IDFWRUV LQÀXHQFLQJ EUHDVW HQGRFULQH HQYLURQPHQW
8QWLOVXFKWKHVLVLVFRQ¿UPHGE\SURVSHFWLYHREVHUYDWLRQVEUHDVW
FDQFHU ULVN HVWLPDWLRQ ZLWK HSLGHPLRORJLFDO PRGHOV VKRXOG QRW
GHWHUDWKRURXJKFOLQLFDODQGUDGLRORJLFDODVVHVVPHQWRIZRPHQ
SUHVHQWLQJZLWKEUHDVWSDLQ
Conclusions
%UHDVW SDLQ ZDV DVVRFLDWHG ZLWK ORZHU HVWLPDWHG EUHDVW
FDQFHUULVNEXWKDGQRHIIHFWRQVFUHHQLQJRXWFRPHVLQWKHVWXG\
SRSXODWLRQ
Conflict of interest statement
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the bioethical committee of the Polish Mother's Memorial Institute in Lodz, Poland in February, 2009.
References
1. McPherson C, Nissen M. Evaluating a risk-based model for mammographic screening of women in their forties. Cancer. 2002, 94, 2830-2835.
2. Rogulski L, Oszukowski P. Epidemiological models for breast cancer risk estimation. Ginekol Pol. 2011, 82, 451-454.
3. Gail M, Brinton L, Byar D, [et al.]. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 81, 1879- 1886.
4. Tyrer J, Duffy S, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Statist Med. 2004, 23, 1111–1130.
5. Mansel R, Webster D, Sweetland H. Breast pain and nodularity. In: Hughes, Mansel & Webster’s Benign Disorders and Diseases of the Breast. 3rd ed. New York: Saunders Elsevier, 2009, 114- 118.
6. Khan S, Apkarian A. The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat. 2002, 75, 147-157.
7. Fariselli G, Lepera P, Viganotti G, [et al.]. Localized mastalgia as presenting symptom in breast cancer. Eur J Surg Oncol. 1988, 14, 213-215.
8. Khan S, Apkarian A. Mastalgia and breast cancer: a protective association? Cancer Detect Prev.
2002, 26, 192-196.
9. Duijm L, Guit G, Hendriks J, [et al.]. Value of breast imaging in women with painful breasts:
observational follow up study. BMJ. 1998, 317, 1492-1495.
10. Pieta B, Samulak D, Opala T, [et al.]. Analysis of odds ratio of increased relative risk of developing breast cancer in different groups of women. Eur J Gynaecol Oncol. 2010, 31, 50-54.
11. Pieta B, Grodecka-Gazdecka S, Chmaj-Wierzchowska K, [et al.]. Analysis of the odds ratio for developing breast cancer in women. Ginekol Pol. 2011, 82, 755-760.